However, it is still necessary to test whether and how blocking CCR6 and CCR8 affects the activities of their endogenous ligands, which are known to be upregulated, as is well documented for CCL1 and CCL20 after nerve and brain injury, respectively (Table 1). This evidence concerns the gene CCL20 and brain injury.